Search

everythinglearnresearchcommunity

for

Search:↓

Trichohyalin in hair can trigger immune attacks in alopecia areata.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

Environmental factors like diet and vitamin levels, especially Vitamin D, can affect autoimmune diseases differently, with lifestyle changes potentially improving outcomes.

The SARS-CoV-2 vaccine may be linked to triggering autoimmune conditions like Alopecia Areata.

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Alopecia areata is an autoimmune condition causing hair loss due to the immune system attacking hair follicles, often influenced by genetics and stress.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Traditional Chinese medicinal foods may help manage long-term post-COVID symptoms.

Baricitinib treatment for alopecia universalis can cause hair regrowth with unexpected whitening.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

Scientists are still unsure what triggers the immune system to attack hair follicles in Alopecia areata.

TLR-targeted therapies show promise in cancer treatment by helping destroy tumors.

RANKL causes lymph nodes to grow by making certain cells multiply.

Men and women get COVID-19 at similar rates, but men tend to get sicker and have a higher risk of dying, while women usually have stronger immune responses and vaccine reactions.

Thyroid and skin autoimmune diseases share genetic and immune links, affecting both tissues.

Low vitamin D may increase autoimmune thyroid disease risk, but its treatment effects are unclear.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

Oral lichen planus is a chronic disease causing mouth discomfort and sometimes needs immunosuppressive treatment.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

CCCA involves immune response and metabolism issues, suggesting new treatment options.